112 related articles for article (PubMed ID: 16087267)
1. Skin permeation and stability studies of 5-aminolevulinic acid in a new gel and patch preparation.
Valenta C; Auner BG; Loibl I
J Control Release; 2005 Oct; 107(3):495-501. PubMed ID: 16087267
[TBL] [Abstract][Full Text] [Related]
2. Influence of 6-ketocholestanol on skin permeation of 5-aminolevulinic acid and evaluation of chemical stability.
Auner BG; Petzenhauser E; Valenta C
J Pharm Sci; 2004 Nov; 93(11):2780-7. PubMed ID: 15378565
[TBL] [Abstract][Full Text] [Related]
3. The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum.
Winkler A; Müller-Goymann CC
Eur J Pharm Biopharm; 2005 Aug; 60(3):427-37. PubMed ID: 15996584
[TBL] [Abstract][Full Text] [Related]
4. Transdermal delivery from a lipid sponge phase--iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester.
Merclin N; Bender J; Sparr E; Guy RH; Ehrsson H; Engström S
J Control Release; 2004 Nov; 100(2):191-8. PubMed ID: 15544867
[TBL] [Abstract][Full Text] [Related]
5. Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches.
Morrow DI; McCarron PA; Woolfson AD; Juzenas P; Juzeniene A; Iani V; Moan J; Donnelly RF
J Pharm Pharmacol; 2010 Jun; 62(6):685-95. PubMed ID: 20636855
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions.
McCarron PA; Donnelly RF; Zawislak A; Woolfson AD
Eur J Pharm Sci; 2006 Feb; 27(2-3):268-79. PubMed ID: 16330192
[TBL] [Abstract][Full Text] [Related]
7. Influence of carrageenan on the rheology and skin permeation of microemulsion formulations.
Valenta C; Schultz K
J Control Release; 2004 Mar; 95(2):257-65. PubMed ID: 14980774
[TBL] [Abstract][Full Text] [Related]
8. Skin permeation enhancement potential of Aloe Vera and a proposed mechanism of action based upon size exclusion and pull effect.
Cole L; Heard C
Int J Pharm; 2007 Mar; 333(1-2):10-6. PubMed ID: 17088033
[TBL] [Abstract][Full Text] [Related]
9. Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application.
McCarron PA; Donnelly RF; Andrews GP; Woolfson AD
J Pharm Sci; 2005 Aug; 94(8):1756-71. PubMed ID: 15986458
[TBL] [Abstract][Full Text] [Related]
10. Development and ex vivo evaluation of 5-aminolevulinic acid-loaded niosomal formulations for topical photodynamic therapy.
Bragagni M; Scozzafava A; Mastrolorenzo A; Supuran CT; Mura P
Int J Pharm; 2015 Oct; 494(1):258-63. PubMed ID: 26283280
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography assay for 5-aminolevulinic acid: application to in vitro assessment of skin penetration via Dermaportation.
Namjoshi S; Caccetta R; Edwards J; Benson HA
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):49-55. PubMed ID: 17236824
[TBL] [Abstract][Full Text] [Related]
12. Effect of selected fluorinated drugs in a "ringing" gel on rheological behaviour and skin permeation.
Höller S; Valenta C
Eur J Pharm Biopharm; 2007 Apr; 66(1):120-6. PubMed ID: 17055710
[TBL] [Abstract][Full Text] [Related]
13. Influence of lipophilic counter-ions in combination with phloretin and 6-ketocholestanol on the skin permeation of 5-aminolevulinic acid.
Auner BG; Valenta C; Hadgraft J
Int J Pharm; 2003 Apr; 255(1-2):109-16. PubMed ID: 12672607
[TBL] [Abstract][Full Text] [Related]
14. Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy.
Al-Kassas R; Donnelly RF; McCarron PA
J Pharm Pharmacol; 2009 Sep; 61(9):1125-35. PubMed ID: 19703361
[TBL] [Abstract][Full Text] [Related]
15. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy.
Donnelly RF; Morrow DI; McCarron PA; Woolfson AD; Morrissey A; Juzenas P; Juzeniene A; Iani V; McCarthy HO; Moan J
J Control Release; 2008 Aug; 129(3):154-62. PubMed ID: 18556084
[TBL] [Abstract][Full Text] [Related]
16. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
[TBL] [Abstract][Full Text] [Related]
17. Development of a stable solution of 5-aminolaevulinic acid for intracutaneous injection in photodynamic therapy.
de Blois AW; Grouls RJ; Ackerman EW; Wijdeven WJ
Lasers Med Sci; 2002; 17(3):208-15. PubMed ID: 12181635
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias.
McCarron PA; Donnelly RF; Woolfson AD
Pharm Res; 2008 Apr; 25(4):812-26. PubMed ID: 17657596
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro percutaneous penetration of 5-aminolevulinic acid and two of its esters through excised hairless mouse skin.
van den Akker JT; Holroyd JA; Vernon DI; Sterenborg HJ; Brown SB
Lasers Surg Med; 2003; 33(3):173-81. PubMed ID: 12949947
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in vivo efficacy of topical formulations containing soybean extract.
Georgetti SR; Casagrande R; Verri WA; Lopez RF; Fonseca MJ
Int J Pharm; 2008 Mar; 352(1-2):189-96. PubMed ID: 18079076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
